Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04397068
Other study ID # S58904
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2016
Est. completion date March 31, 2017

Study information

Verified date May 2020
Source Universitaire Ziekenhuizen Leuven
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to gain more insight into the potential impact of a vitrectomy (removal of the vitreous) on postoperative effective position of the intraocular lens (IOL). Moreover, this study can provide very useful information for the optimal lens calculation in patients undergoing lens extraction with IOL implantation (whether or not combined with a vitrectomy) should undergo.


Description:

- Comparison ELP post phaco VTX (pucker / floaters) versus post phaco and use this information to develop a customized IOL calculation for eyes undergoing phacoVTX.

- Evidence for recording lens thickness (LT) parameter in the IOL strength calculation in KWS (in the calculation of the ELP in the light of the Olsen formula, using the C-constant) in order to be able to make an even more accurate prediction of the post-operative diopter target of the patient.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date March 31, 2017
Est. primary completion date March 31, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria:

- age > 50 yrs

- macular pucker wherefore vitrectomy is necessary

Exclusion Criteria:

- macular pathology other than macular pucker

- Corneal pathology

- Other ocular pathology that could affect the biometrics or ELP

- Previous vitrectomy in one of the eyes

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
phaco-vitrectomy
phaco-vitrectomy. No other involvement drug or device. Standard of care procedure

Locations

Country Name City State
Belgium Universitaire Ziekenhuizen Leuven Leuven

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compare if ELP is different or the same at phaco or phaco-vitrectomy Anterior chamber depth measured using IOL master. 6 - 8 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT01969929 - Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy N/A
Completed NCT00555269 - Membrane Blue Versus Infracyanine Green N/A
Completed NCT03934190 - Inner Nuclear Macular Microcyst is a Risk Factor for Macular Cystoid Changes After Phacoemulsification in Eyes With Previous Vitrectomy and Macular Pucker Removal
Terminated NCT04802265 - EpiRetinal Membrane Peeling and Internal Limiting Membrane
Completed NCT02319655 - Morphologic Changes After Membrane Peeling With Air Tamponade and Balanced Salt Solution N/A
Completed NCT05517473 - Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains
Completed NCT01162356 - Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study N/A
Recruiting NCT01083004 - Brilliant Blue Versus Indocyanine Green Phase 3
Recruiting NCT04802915 - Intraoperative Analysis of the Central Retina in ERF N/A
Recruiting NCT04501367 - Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker. Phase 4
Recruiting NCT05860985 - Zeiss RESIGHT Disposable Lenses Evaluation Study N/A